Journal Article

Singing for lung health following completion of pulmonary rehabilitation: feasibility of a randomised controlled trial

Ingram, Karen A, Young, Susan, Longley, Noah, Alexander, Sharon, Watters, Rosie, Harris, Amanda, Lohan, Natasha, Lammin, Helen, Man, William D-C, DeLuca, Brendan, Sorley, Kim, Philip, Keir Elmslie James, Smith, Laura-Jane, Sureshkumar, Arun, Banya, Winston, Koulopoulou, Maria, Elkin, Sarah, Lound, Adam, Edwards, George, Garsin, Emily, Steinmann, Jennifer, Williams, Parris, Jung, Peter, Lewis, Adam, Cave, Phoene, Maguire, Michelle, Conway, Joy, Trivedi, Puja, Hopkinson, Nicholas S, Moth, Laura, Rickman, Penelope, Moore, Anna, Clarke, Stuart, Kenman, Jarvis, Reardon, Leanne, Lane, Cleo, Pfeffer, Paul E, Nolan, Claire M, Anokye, Nana

2026

Overview

BackgroundPulmonary rehabilitation (PR) is a highly effective intervention for people with chronic respiratory disease; however, it is not known how best to sustain its benefits. Clinical trials are needed to establish if participation in singing for lung health (SLH) groups following PR will improve health-related quality of life, healthcare utilisation and exercise capacity compared with usual care. A feasibility study would help to guide development of these trials.MethodsIn a multicentre, mixed-methods randomised controlled feasibility trial, PR participants at four sites were prescreened at baseline assessment. An SLH taster session was included routinely as part of the PR programmes. Eligible PR completers were invited to take part in the trial and randomised to usual care or a 12-week SLH course. Feasibility outcomes included recruitment rate, intervention compliance (at least 8/12 sessions) and health economic analysis. Interviews with participants and study personnel were undertaken and thematic analysis of the results was completed.ResultsBetween October 2022 and November 2023, 1311 patients were assessed to start PR, 838 completed. Of those completing, 243 were ineligible to take part (predominantly due to vaccination status and excluded diagnoses for PR referral), and 531 declined. 64 people (33 female, mean (SD) age 69 (12), 41 ethnically white, 33 with chronic obstructive pulmonary disease, 16 with asthma, 9 with interstitial lung disease, 6 with bronchiectasis) were recruited, with 30 (93.8%) SLH and 29 (90.6%) controls completing the study. 20 (62.5%) of the SLH group completed at least 8/12 SLH sessions. There was enthusiasm for a definitive trial from participants, clinicians and singing group leaders’ perspectives, based on positive experiences of trial involvement. Improvements to recruitment strategy, intervention structure, outcome measures and staffing were suggested.ConclusionsA definitive randomised controlled trial of SLH post-PR appears feasible, with acceptable uptake and completion rates.Trial registration numberISRCTN11056049.

• Publisher: British Thoracic Society,BMJ Publishing Group LTD,BMJ Publishing Group
• Subject: Aged / Asthma / Bronchiectasis / Chronic obstructive pulmonary disease / Clinical trials / Emphysema / Exercise / Exercise Tolerance / Feasibility / Feasibility Studies / Female / Hospitalization / Humans / Male / Middle Aged / Mortality / Patients / Perception of Asthma/Breathlessness / Physical fitness / Pulmonary Disease, Chronic Obstructive - rehabilitation / Pulmonary Rehabilitation / Quality of Life / Quality standards / Questionnaires / Rehabilitation / Respiratory diseases / Respiratory research / Singing